A Genome-Wide Scan for Loci Linked to Plasma Levels of Glucose and HbA1c in a Community-Based Sample of Caucasian Pedigrees

The Framingham Offspring Study

  1. James B. Meigs1,
  2. Carolien I. M. Panhuysen2,
  3. Richard H. Myers3,
  4. Peter W.F. Wilson45 and
  5. L. Adrienne Cupples2
  1. 1General Internal Medicine and Clinical Epidemiology Units, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  2. 2Department of Epidemiology and Biostatistics, Boston University School of Public Health and School of Medicine, Boston, Massachusetts
  3. 3Department of Neurology, Boston University School of Medicine, Boston, Massachusetts
  4. 4Framingham Heart Study, Framingham, Massachusetts
  5. 5Boston University School of Medicine, Boston, Massachusetts

    Abstract

    Elevated blood glucose levels are the hallmark of type 2 diabetes as well as a powerful risk factor for development of the disease. We conducted a genome-wide search for diabetes-related genes, using measures of glycemia as quantitative traits in 330 pedigrees from the Framingham Heart Study. Of 3,799 attendees at the 5th Offspring Study exam cycle (1991–1995), 1,461, 1,251, and 771 men (49%) and women provided information on levels of 20-year mean fasting glucose, current fasting glucose, and HbA1c, respectively, and 1,308 contributed genotype data (using 401 microsatellite markers with an average spacing of 10 cM). Levels of glycemic traits were adjusted for age, cigarette smoking, alcohol and estrogen use, physical activity, and BMI. We ranked standardized residuals from these models, created normalized deviates from the ranks, and used the variance component model implemented in SOLAR (Sequential Oligogenic Linkage Analysis Routines) to evaluate linkage to normalized deviates as quantitative traits. We found peak evidence for linkage to 20-year mean fasting glucose levels on chromosome 1 at ∼247 cM from p-telomere (pter) (multipoint logarithm of odds [LOD] 2.33) and on chromosome 10 at ∼86 cM from pter (multipoint LOD 2.07); to current fasting glucose levels on chromosome 1 at ∼218 cM from pter (multipoint LOD 1.80) and on chromosome 10 at ∼96 cM from pter (multipoint LOD 2.15); and to HbA1c levels on chromosome 1 at ∼187 cM (multipoint LOD 2.81). This analysis of unselected European Caucasian pedigrees suggests localization of quantitative trait loci influencing glucose homeostasis on chromosomes 1q and 10q. Findings at ∼187–218 cM on chromosome 1 appear to replicate linkage reported in previous studies of other populations, pointing to this large chromosomal region as worthy of more detailed scrutiny in the search for type 2 diabetes susceptibility genes.

    Footnotes

    • Address correspondence and reprint requests to James B. Meigs, MD, MPH, General Medicine Division, Massachusetts General Hospital, 50 Staniford St. 9th Floor, Boston, MA 02114. E-mail: jmeigs{at}partners.org.

      Received for publication 11 December 2000 and accepted in revised form 27 November 2001.

      Additional information for this article can be found in an online supplement at http://diabetes.diabetesjournals.org.

      IBD, identical by descent; LOD, logarithm of odds; pter, p-telomere; QTL, quantitative trait locus.

    | Table of Contents